Pyxis Oncology (PYXS) Return on Equity [ROE] (2021 - 2026)
Pyxis Oncology (PYXS) reported Return on Equity [ROE] of -258.52% for Q2 2026, down 154.76 percentage points from -103.77% a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Pyxis Oncology posted Return on Equity [ROE] of -91.45%, down 28.70 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of -34.71 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -62.75% in FY2024 (-11.18 pp), -51.58% in FY2023 (+5.62 pp), -57.19% in FY2022 (-0.45 pp) and -56.74% in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- Year over year, Return on Equity [ROE] gained in 1 of the last seven quarters, with an average year-over-year change of -58.08 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2024 (a gain of 32.38 percentage points); the low point was Q2 2026 (a drop of 154.76 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Pyxis Oncology | 136.12 Mn | -60.32 Mn | - | -329.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -329.16% |
| Jun 30, 2026 | -415.50% |
| Mar 31, 2026 | -193.17% |
| Dec 31, 2025 | -130.52% |
| Sep 30, 2025 | -124.49% |
| Jun 30, 2025 | -100.86% |
| Mar 31, 2025 | -84.99% |
| Dec 31, 2024 | -56.28% |
| Sep 30, 2024 | -35.18% |
| Jun 30, 2024 | -33.46% |
| Mar 31, 2024 | -37.80% |
| Dec 31, 2023 | -55.93% |
| Sep 30, 2023 | -66.66% |
| Jun 30, 2023 | -66.57% |
| Mar 31, 2023 | -68.94% |
| Dec 31, 2022 | -69.07% |
| Sep 30, 2022 | -50.43% |
| Jun 30, 2022 | -38.15% |
| Mar 31, 2022 | -26.41% |
| Dec 31, 2021 | -73.41% |
API Access
Pyxis Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();